222 related articles for article (PubMed ID: 3129126)
1. D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats.
Karoum F; Freed WJ; Chuang LW; Cannon-Spoor E; Wyatt RJ; Costa E
Brain Res; 1988 Feb; 440(1):190-4. PubMed ID: 3129126
[TBL] [Abstract][Full Text] [Related]
2. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Treseder SA; Rose S; Jenner P
Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-dopa.
Brannan T; Knott P; Kaufmann H; Leung L; Yahr M
J Neural Transm; 1989; 75(2):149-57. PubMed ID: 2918307
[TBL] [Abstract][Full Text] [Related]
4. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat.
Brannan T; Prikhojan A; Yahr MD
Brain Res; 1996 Apr; 718(1-2):165-8. PubMed ID: 8773780
[TBL] [Abstract][Full Text] [Related]
5. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
Brannan T; Bhardwaj A; Martinez-Tica J; Weinberger J; Yahr M
J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388
[TBL] [Abstract][Full Text] [Related]
6. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Wachtel SR; Abercrombie ED
J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
8. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms.
Robertson GS; Robertson HA
J Neurosci; 1989 Sep; 9(9):3326-31. PubMed ID: 2795165
[TBL] [Abstract][Full Text] [Related]
9. The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.
Blunt SB; Jenner P; Marsden CD
Neuroscience; 1991; 43(1):95-110. PubMed ID: 1681462
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
Sarre S; Herregodts P; Deleu D; Devrieze A; De Klippel N; Ebinger G; Michotte Y
Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
[TBL] [Abstract][Full Text] [Related]
11. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
Rose S; Jenner P; Marsden CD
Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
[TBL] [Abstract][Full Text] [Related]
12. Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease.
Nakazato T; Akiyama A
Brain Res; 2002 Mar; 930(1-2):134-42. PubMed ID: 11879803
[TBL] [Abstract][Full Text] [Related]
13. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
Gołembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
14. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
Brannan T; Knott P; Kaufmann H; Yahr M
Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
[No Abstract] [Full Text] [Related]
16. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
Hefti F; Melamed E
Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
[TBL] [Abstract][Full Text] [Related]
17. Effect of nitecapone and clorgyline, given intracerebro-ventricularly on L-dopa metabolism in the rat brain.
Männistö PT; Törnwall M; Tuomainen P; Borisenko SA; Tuominen RK
Neuroreport; 1992 Jul; 3(7):641-4. PubMed ID: 1421124
[TBL] [Abstract][Full Text] [Related]
18. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
Xu K; Dluzen DE
J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
[TBL] [Abstract][Full Text] [Related]
19. Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
Carey RJ
Brain Res; 1991 Dec; 568(1-2):205-14. PubMed ID: 1814568
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic effects of L-dopa are not closely linked temporally to striatal dopamine concentration.
Spencer SE; Wooten GF
Neurology; 1984 Dec; 34(12):1609-11. PubMed ID: 6504335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
